BCM
ORGO icon

Bluefin Capital Management’s Organogenesis Holdings ORGO Stock Holding History

Bluefin Capital Management’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-37,108
Closed -$369K – 577
2017
Q1 		$369K Buy
+37,108
New +$367K 0.05% 232

Other funds holding ORGO

AIM
Assured Investment Management New York $79.5M AUM 115.55% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
FTCM
Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return
MCM
Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
LIM
Longfellow Investment Management Boston, Massachusetts $480M AUM 8% 1-Year Est. Return
WRBC
W.R. Berkley Corp Greenwich, Connecticut $1.86B AUM 14.44% 1-Year Est. Return
BCM
Basso Capital Management Stamford, Connecticut $163M AUM 21.95% 1-Year Est. Return
HIM
HGC Investment Management Toronto, Ontario, Canada $451M AUM 8.78% 1-Year Est. Return

Bluefin Capital Management's ORGO Position: Q2 2017 in Review

Bluefin Capital Management sold out of Organogenesis Holdings (ORGO) in Q2 2017, closing a stake of 37,108 shares — an estimated $369K sold.

Bluefin Capital Management first reported a position in ORGO in Q1 2017 and held it in 1 quarter. The position peaked at $369K in Q1 2017. 18 funds tracked by Wall St. Rank hold ORGO as of Q2 2017.

  • Bluefin Capital Management reported no remaining Organogenesis Holdings position as of Q2 2017 after selling out during the quarter.
  • Bluefin Capital Management sold 37,108 Organogenesis Holdings shares in Q2 2017, an estimated $369K.
  • Bluefin Capital Management first reported a position in Organogenesis Holdings in Q1 2017 and held it in 1 quarter.
  • Bluefin Capital Management's Organogenesis Holdings position peaked at $369K in Q1 2017.
  • 18 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2017.

Based on Bluefin Capital Management's 13F filing for Q2 2017, filed 15 Aug 2017.